BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 24122985)

  • 1. Biological correlation of ¹⁸F-FDG uptake on PET in pulmonary neuroendocrine tumors.
    Kaira K; Murakami H; Endo M; Ohde Y; Naito T; Kondo H; Nakajima T; Yamamoto N; Takahashi T
    Anticancer Res; 2013 Oct; 33(10):4219-28. PubMed ID: 24122985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer.
    Kaira K; Serizawa M; Koh Y; Takahashi T; Yamaguchi A; Hanaoka H; Oriuchi N; Endo M; Ohde Y; Nakajima T; Yamamoto N
    Lung Cancer; 2014 Feb; 83(2):197-204. PubMed ID: 24365102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic correlates of ¹⁸F-FDG uptake on PET in pulmonary pleomorphic carcinoma.
    Kaira K; Endo M; Abe M; Nakagawa K; Ohde Y; Okumura T; Takahashi T; Murakami H; Tsuya A; Nakamura Y; Naito T; Hayashi I; Kondo H; Nakajima T; Yamamoto N
    Lung Cancer; 2011 Feb; 71(2):144-50. PubMed ID: 20646779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between 18F-FDG uptake on PET and molecular biology in metastatic pulmonary tumors.
    Kaira K; Okumura T; Ohde Y; Takahashi T; Murakami H; Oriuchi N; Endo M; Kondo H; Nakajima T; Yamamoto N
    J Nucl Med; 2011 May; 52(5):705-11. PubMed ID: 21498541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG uptake on PET in primary mediastinal non-thymic neoplasm: a clinicopathological study.
    Kaira K; Abe M; Nakagawa K; Ohde Y; Okumura T; Takahashi T; Murakami H; Shukuya T; Kenmotsu H; Naito T; Hayashi I; Oriuchi N; Endo M; Kondo H; Nakajima T; Yamamoto N
    Eur J Radiol; 2012 Sep; 81(9):2423-9. PubMed ID: 22055682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors.
    Kaira K; Endo M; Abe M; Nakagawa K; Ohde Y; Okumura T; Takahashi T; Murakami H; Tsuya A; Nakamura Y; Naito T; Hayashi I; Serizawa M; Koh Y; Hanaoka H; Tominaga H; Oriuchi N; Kondo H; Nakajima T; Yamamoto N
    J Clin Oncol; 2010 Aug; 28(23):3746-53. PubMed ID: 20625125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between 18F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesothelioma.
    Kaira K; Serizawa M; Koh Y; Takahashi T; Hanaoka H; Oriuchi N; Endo M; Kondo H; Nakajima T; Yamamoto N
    Eur J Cancer; 2012 May; 48(8):1244-54. PubMed ID: 22330319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Deoxy-2-[fluorine-18] fluoro-d-glucose uptake on positron emission tomography is associated with programmed death ligand-1 expression in patients with pulmonary adenocarcinoma.
    Kaira K; Shimizu K; Kitahara S; Yajima T; Atsumi J; Kosaka T; Ohtaki Y; Higuchi T; Oyama T; Asao T; Mogi A
    Eur J Cancer; 2018 Sep; 101():181-190. PubMed ID: 30077123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer.
    Kaira K; Oriuchi N; Shimizu K; Ishikita T; Higuchi T; Imai H; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Endo K; Mori M
    Cancer Sci; 2009 Apr; 100(4):753-8. PubMed ID: 19141127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ¹⁸F-FDG uptake on PET could be a predictive marker of excision repair cross-complementation group 1 (ERCC1) expression in patients with thoracic neoplasms?
    Kaira K; Endo M; Shukuya T; Kenmotsu H; Naito T; Ono A; Tsuya A; Nakamua Y; Takahashi T; Murakami H; Kondo H; Nakajima T; Yamamoto N
    Neoplasma; 2012; 59(3):257-63. PubMed ID: 22329847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ¹⁸F-FDG uptake on PET is a predictive marker of thymidylate synthase expression in patients with thoracic neoplasms.
    Kaira K; Yamamoto N; Endo M; Kenmotsu H; Naito T; Ono A; Murakami H; Ohde Y; Nakajima T; Takahashi T
    Oncol Rep; 2014 Jan; 31(1):209-15. PubMed ID: 24173608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma.
    Kasahara N; Kaira K; Bao P; Higuchi T; Arisaka Y; Erkhem-Ochir B; Sunaga N; Ohtaki Y; Yajima T; Kosaka T; Oyama T; Yokobori T; Asao T; Nishiyama M; Tsushima Y; Kuwano H; Shimizu K; Mogi A
    Lung Cancer; 2018 May; 119():71-77. PubMed ID: 29656756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between SUV of (18)F-FDG PET-CT and the expression of GLUT1, MVD and Ki67 in non-small cell lung cancer].
    Duan Y; Yu LJ; Lu PO; Wang WZ
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):764-7. PubMed ID: 19173807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer.
    Furukawa T; Miyata Y; Kushitani K; Mimae T; Tsutani Y; Takeshima Y; Okada M
    Jpn J Clin Oncol; 2015 Dec; 45(12):1154-61. PubMed ID: 26386467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of 4F2hc (CD98) in pulmonary neuroendocrine tumors.
    Kaira K; Ohde Y; Endo M; Nakagawa K; Okumura T; Takahashi T; Murakami H; Tsuya A; Nakamura Y; Naito T; Kondo H; Nakajima T; Yamamoto N
    Oncol Rep; 2011 Oct; 26(4):931-7. PubMed ID: 21750865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer.
    van Baardwijk A; Dooms C; van Suylen RJ; Verbeken E; Hochstenbag M; Dehing-Oberije C; Rupa D; Pastorekova S; Stroobants S; Buell U; Lambin P; Vansteenkiste J; De Ruysscher D
    Eur J Cancer; 2007 Jun; 43(9):1392-8. PubMed ID: 17512190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG PET increases visibility of bone lesions in relapsed multiple myeloma: is this hypoxia-driven?
    de Waal EG; Slart RH; Leene MJ; Kluin PM; Vellenga E
    Clin Nucl Med; 2015 Apr; 40(4):291-6. PubMed ID: 25546223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lung.
    Song YS; Lee WW; Chung JH; Park SY; Kim YK; Kim SE
    Lung Cancer; 2008 Jul; 61(1):54-60. PubMed ID: 18191496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorodeoxyglucose uptake is associated with low tumor-infiltrating lymphocyte levels in patients with small cell lung cancer.
    Kasahara N; Kaira K; Yamaguchi K; Masubuchi H; Tsurumaki H; Hara K; Koga Y; Sakurai R; Higuchi T; Handa T; Oyama T; Yokobori T; Shimizu K; Asao T; Hisada T
    Lung Cancer; 2019 Aug; 134():180-186. PubMed ID: 31319979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.